EBS
Emergent BioSolutions Inc
Price:  
3.39 
USD
Volume:  
2,256,839.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

EBS WACC - Weighted Average Cost of Capital

The WACC of Emergent BioSolutions Inc (EBS) is 5.9%.

The Cost of Equity of Emergent BioSolutions Inc (EBS) is 21.25%.
The Cost of Debt of Emergent BioSolutions Inc (EBS) is 5.50%.

Range Selected
Cost of equity 16.50% - 26.00% 21.25%
Tax rate 26.00% - 27.30% 26.65%
Cost of debt 4.00% - 7.00% 5.50%
WACC 4.5% - 7.4% 5.9%
WACC

EBS WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 2.74 3.78
Additional risk adjustments 0.0% 0.5%
Cost of equity 16.50% 26.00%
Tax rate 26.00% 27.30%
Debt/Equity ratio 7.99 7.99
Cost of debt 4.00% 7.00%
After-tax WACC 4.5% 7.4%
Selected WACC 5.9%